Corbus Pharmaceuticals Holding (CRBP)
$15.08 -$0.48 (-3.06%) 4:38 PM 12/12/24
NASDAQ | $USD | BiotechnologyStock Data
-
Market Cap
$185.86M -
Day's Range
$15.05 - $15.88 -
Volume
264,243 -
52 Week Low / High
$4.94 - $61.90 -
PE Ratio
- -
PEG Ratio
- -
Dividend Frequency
-
CRBP's Dividend
Hypothetical 10k Investment Jan 1, 2020
- Capital Growth
- Dividend Return to Date
- Dividend Payout year Est.
- Expenses
- Total Return
- Total Return %
Analyists Ranking
- 6
- Strong Buy
- 2
- Buy
- 0
- Hold
- 0
- Sell
- 0
- Strong Sell
- $71.00
- Target Price
Company News
-
Novo Nordisk's Monlunabant Data Drags Stocks Of Smaller Players — Sep 20th, 2024
Novo Nordisk's Monlunabant Data Drags Stocks Of Smaller Players Earlier on Friday, Novo Nordisk A/S (NYSE:NVO) announced headline results from a phase 2a clinical trial with monlunabant, a small-molecule oral cannabinoid receptor 1 (CB1) inverse agonist. After 16 weeks of treatment, pe...
|
Portfolio
$5,000/year
Goal: $10,000/year
Comprised of 1 portfolios
$